CNS & Neurological Disorders – Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.
CNS & Neurological Disorders – Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Articles from the journal CNS & Neurological Disorders – Drug Targets 16, Issue 3:
- COMMENTARY: Transcranial Magnetic Stimulation in Multiple Sclerosis: A Method to Improve Movement
- Synaptic Plasticity, Dementia and Alzheimer Disease
- Treatment Possibilities for Psychosis in Parkinson’s Disease with An Emphasis on the Newly Approved Drug: Pimavanserin
- Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System
- Purinergic Signalling and Neurological Diseases: An Update
- How Immune-inflammatory Processes Link CNS and Psychiatric Disorders: Classification and Treatment Implications
- The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity
- Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington’s Disease
- Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy
- The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment
- Preventive and Protective Roles of Dietary Nrf2 Activators Against Central Nervous System Diseases
- Cerebrospinal-fluid Alzheimer’s Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson’s Disease Patients
- Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
- Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach
- Axotomy Leads to Reduced Calcium Increase and Earlier Termination of CCL2 Release in Spinal Motoneurons with Upregulated Parvalbumin Followed by Decreased Neighboring Microglial Activation
For details on the articles, please visit this link :: http://bit.ly/2uAKCAM